News Conference News PCR London Valves 2024 Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI Michael O'Riordan December 02, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2024 Shelley Wood November 01, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
Presentation TCT 2024 One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial Presenter: Michael Reardon October 30, 2024
Presentation TCT 2024 TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up Presenter: Ignacio Amat-Santos October 28, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024